Given the implication of dopamine dysregulation and dopamine transporter in ADHD, we are curious about whether the D2R-DAT protein complex will prove to be a viable therapeutic target for ADHD. The gene discussed is DRD2; the disease is attention deficit-hyperactivity disorder.